We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.02B
AUM Growth
-$1.32M
Cap. Flow
-$27.2M
Cap. Flow %
-2.65%
Top 10 Hldgs %
36.57%
Holding
447
New
77
Increased
110
Reduced
140
Closed
93

Top Sells

Rank Stock Value
1
DEN
Denbury Inc.
DEN
+$28.4M
2
AR icon
Antero Resources
AR
+$22.5M
3
IMO icon
Imperial Oil
IMO
+$11.8M
4
ABBV icon
AbbVie
ABBV
+$9.22M
5
DAC icon
Danaos Corp
DAC
+$8.26M

Sector Composition

Rank Sector Weight
1 Energy 35.09%
2 Technology 13.02%
3 Healthcare 11.46%
4 Industrials 9.72%
5 Financials 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRD
151
DELISTED
Beard Energy Transition Acquisition Corp.
BRD
$1.1M 0.11%
109,450
-13,800
-11% -$137K
AXP icon
152
American Express
AXP
$223B
$1.09M 0.11%
8,062
-66
-0.8% -$9.99K
YTPG
153
DELISTED
TPG Pace Beneficial II Corp.
YTPG
$1.08M 0.11%
110,628
-17,610
-14% -$172K
LEU icon
154
Centrus Energy
LEU
$3.22B
$1.07M 0.1%
+26,118
New +$1M
PCN
155
PIMCO Corporate & Income Strategy Fund
PCN
$870M
$1.07M 0.1%
90,000
MAIN icon
156
Main Street Capital
MAIN
$4.97B
$1.06M 0.1%
31,565
+1,177
+4% +$48.5K
PRVB
157
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1.06M 0.1%
235,000
TMO icon
158
Thermo Fisher Scientific
TMO
$211B
$1.06M 0.1%
2,084
-8
-0.4% -$4.48K
BXSL icon
159
Blackstone Secured Lending
BXSL
$5.41B
$1.05M 0.1%
46,192
+8,107
+21% +$193K
AXGN icon
160
Axogen
AXGN
$2.1B
$1.04M 0.1%
+87,078
New +$871K
VO icon
161
Vanguard Mid-Cap ETF
VO
$106B
$1.03M 0.1%
22,020
HTGC icon
162
Hercules Capital
HTGC
$2.94B
$1.03M 0.1%
89,258
+10,458
+13% +$149K
RXRX icon
163
Recursion Pharmaceuticals
RXRX
$1.57B
$1.03M 0.1%
96,803
+34,999
+57% +$354K
LRCX icon
164
Lam Research
LRCX
$382B
$1.01M 0.1%
27,600
-310
-1% -$13.8K
TXRH icon
165
Texas Roadhouse
TXRH
$12.7B
$994K 0.1%
11,391
-215
-2% -$18.8K
AKYA
166
DELISTED
Akoya BioSciences
AKYA
$989K 0.1%
+84,113
New +$1.11M
ARCO icon
167
Arcos Dorados Holdings
ARCO
$1.73B
$984K 0.1%
135,062
-362
-0.3% -$2.61K
CRDO icon
168
Credo Technology Group
CRDO
$39.7B
$969K 0.09%
+88,061
New +$1.16M
DOL icon
169
WisdomTree True Developed International Fund
DOL
$813M
$967K 0.09%
25,850
BRLT icon
170
Brilliant Earth
BRLT
$18.5M
$964K 0.09%
+168,109
New +$1.09M
CW icon
171
Curtiss-Wright
CW
$27.7B
$938K 0.09%
6,741
+2,458
+57% +$349K
NSSC icon
172
Napco Security Technologies
NSSC
$1.28B
$935K 0.09%
+32,156
New +$859K
MCD icon
173
McDonald's
MCD
$188B
$931K 0.09%
4,037
-24
-0.6% -$6.13K
DAC icon
174
Danaos Corp
DAC
$2.55B
$930K 0.09%
16,703
-124,312
-88% -$8.26M
TSLA icon
175
Tesla
TSLA
$1.24T
$920K 0.09%
3,467
+239
+7% +$66.7K

Similar funds

Advisory Research's Q3 2022 Portfolio in Review

As of Q3 2022, Advisory Research held 447 positions worth $1.02B, down 0.13% from $1.02B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Advisory Research's Q3 2022 filing shows 77 new, 110 increased, 140 reduced and 93 closed positions. Its largest new stake was Velo3D, Inc.: 38,954 shares worth $5.37M. The largest sale was Denbury Inc., an estimated $28.4M.

By sector, the portfolio is most concentrated in Energy at 35% of assets, down from 36% a quarter earlier, followed by Technology and Healthcare.

  • Advisory Research's largest Q3 2022 buy was Velo3D, Inc.: 38,954 shares worth $5.37M.
  • Advisory Research added most to Equinor in Q3 2022, an estimated $9.87M increase.
  • Advisory Research's biggest Q3 2022 reduction was Denbury Inc., cutting an estimated $28.4M.
  • Advisory Research fully exited Imperial Oil in Q3 2022, selling an estimated $11.8M.
  • Advisory Research's ten largest holdings make up 37% of its $1.02B portfolio in Q3 2022.
  • Advisory Research opened 77 new positions and closed 93 in Q3 2022.
  • Advisory Research's portfolio value fell 0.13% quarter-over-quarter to $1.02B.

Based on Advisory Research's 13F filing for Q3 2022, filed 15 Nov 2022.